Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Network toxicology and molecular docking analyses on strychnine indicate CHRM1 is a potential neurotoxic target

Fig. 6

Molecular docking of key target compounds, the bottom diagram shows the 3D structure of the ligand and the receptor, while the top diagram shows the 3D structure of the receptor surface and the ligand. A Docking process of (S)-Stylopine with CHRM1. B Docking process of Isobrucine with CHRM1. C Docking process of Stigmasterol with CHRM1. * The red dotted line indicates the H-bond force between the compound and CHRM1protein

Back to article page